Reducing or eliminating the need for chronic immunosuppressive therapy by inducing tolerance in the recipient immune system would have an astounding impact on clinical practice and scientists all… read more.
by Maria Dalby – Kidney transplants could in principle last forever – the common assumption that kidney transplants inevitably deteriorate and fail is not supported by the latest… read more.
by Maria Dalby – Donor-specific anti-human leukocyte antigen (HLA) antibodies, or DSAs, have emerged in recent years as one of the most important factors for predicting the outcome… read more.
by Mr Nizam Mamode (pictured) – This year’s European Society for Organ Transplantation meeting, held in Vienna, saw a concerted attempt at providing a high quality congress for… read more.
FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.
Johns Hopkins researchers see 21-fold increase in a single day. A social media push boosted the number of people who registered themselves as organ donors 21-fold in a… read more.
Taken from the NEJM – by Bruce Sylvester – Three biomarkers in the urine of kidney transplant recipients can be used to diagnose and predict transplant rejection, researchers… read more.
A newly-described immunodeficiency syndrome of neutrophil defects, bone marrow fibrosis, nephromegaly, and life-threatening infections arises from a genetic mutation that impairs movement of proteins within cells, researchers found.
Researchers reported encouraging but preliminary results of gene-based immune therapy in two children with relapsed and refractory acute lymphoblastic leukemia (ALL).
by Maria Dalby reporting on the presentation by Steve Woodle, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. The future of treatment of antibody-mediated rejection (AMR) may… read more.
by Maria Dalby reporting on the presentation by Anthony Dorling, King’s College London. The presence of Human Leukocyte Antigen (HLA) antibodies in renal transplant recipients is increasingly recognised… read more.
by Maria Dalby reporting on the presentation by William McKane, Sheffield Teaching Hospitals NHS Foundation Trust & Declan de Freitas, Beaumont Hospital, Dublin, Ireland. Pre-transplant and de novo… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
